14:20 EDT Syndax (SNDX) trading resumes
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNDX:
- Syndax confirms FDA approves second indication for Revuforj
- FDA approves Syndax’s revumenib for relapsed or refractory AML
- Syndax trading halted, news pending
- Syndax assumed with a Buy at H.C. Wainwright
- Strategic Positioning and Competitive Edge: Syndax Pharmaceuticals’ Buy Rating Reinforced by Revuforj’s Milestones in Leukemia Treatment